Literature DB >> 19708019

Toward general prophylactic cancer vaccination.

Uwe Hobohm1.   

Abstract

It is well established that chronic infections can lead to cancer. Almost unknown is that, in contrast, acute brief viral and bacterial infections may have beneficial effects in cases of established neoplastic disease, while exposure to pathogenic products by infection, vaccination, and inhalation can cause prophylactic effects. In the following I will align evidence from case studies of spontaneous regression and from epidemiological studies with recent immunology to conclude that pathogenic substances belonging to the group of "pathogen-associated molecular patterns" can trigger the innate immune system to establish anti-neoplastic immune responses. A better understanding of the protective role of the innate immune system might leverage considerable prophylactic potential.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19708019     DOI: 10.1002/bies.200900025

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  10 in total

Review 1.  Protecting the normal in order to better kill the cancer.

Authors:  Bingya Liu; Lewis Ezeogu; Lucas Zellmer; Baofa Yu; Ningzhi Xu; Dezhong Joshua Liao
Journal:  Cancer Med       Date:  2015-07-14       Impact factor: 4.452

Review 2.  Necrosis, and then stress induced necrosis-like cell death, but not apoptosis, should be the preferred cell death mode for chemotherapy: clearance of a few misconceptions.

Authors:  Ju Zhang; Xiaomin Lou; Longyu Jin; Rongjia Zhou; Siqi Liu; Ningzhi Xu; D Joshua Liao
Journal:  Oncoscience       Date:  2014-07-03

3.  Infections and cancer: the "fifty shades of immunity" hypothesis.

Authors:  Camille Jacqueline; Aurélie Tasiemski; Gabriele Sorci; Beata Ujvari; Fatima Maachi; Dorothée Missé; François Renaud; Paul Ewald; Frédéric Thomas; Benjamin Roche
Journal:  BMC Cancer       Date:  2017-04-12       Impact factor: 4.430

4.  Safety of Therapeutic Fever Induction in Cancer Patients Using Approved PAMP Drugs.

Authors:  Uwe Rudolf Max Reuter; Ralf Oettmeier; Uwe Hobohm
Journal:  Transl Oncol       Date:  2018-02-07       Impact factor: 4.243

Review 5.  Evidence for immortality and autonomy in animal cancer models is often not provided, which causes confusion on key issues of cancer biology.

Authors:  Xixi Dou; Pingzhen Tong; Hai Huang; Lucas Zellmer; Yan He; Qingwen Jia; Daizhou Zhang; Jiang Peng; Chenguang Wang; Ningzhi Xu; Dezhong Joshua Liao
Journal:  J Cancer       Date:  2020-03-04       Impact factor: 4.207

6.  Placenta-derived gp96 as a multivalent prophylactic cancer vaccine.

Authors:  Bao Zhao; Yanzhong Wang; Bo Wu; Shan Liu; Erjie Wu; HongXia Fan; MingMing Gui; Lizhao Chen; Changfei Li; Ying Ju; Wei Zhang; Songdong Meng
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

7.  Inpatient treatment of community-acquired pneumonias with integrative medicine.

Authors:  Ulrich Geyer; Klas Diederich; Maria Kusserow; Andreas Laubersheimer; Klaus Kramer
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-22       Impact factor: 2.629

8.  In Hyperthermia Increased ERK and WNT Signaling Suppress Colorectal Cancer Cell Growth.

Authors:  Michael Bordonaro; Senji Shirasawa; Darina L Lazarova
Journal:  Cancers (Basel)       Date:  2016-05-14       Impact factor: 6.639

9.  Culture at a Higher Temperature Mildly Inhibits Cancer Cell Growth but Enhances Chemotherapeutic Effects by Inhibiting Cell-Cell Collaboration.

Authors:  Shengming Zhu; Jiangang Wang; Bingkun Xie; Zhiguo Luo; Xiukun Lin; D Joshua Liao
Journal:  PLoS One       Date:  2015-10-23       Impact factor: 3.240

10.  Fever Therapy With Intravenously Applied Mistletoe Extracts for Cancer Patients: A Retrospective Study.

Authors:  Marc Schläppi; Christoph Ewald; Jürgen Johannes Kuehn; Tomas Weinert; Roman Huber
Journal:  Integr Cancer Ther       Date:  2016-07-07       Impact factor: 3.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.